StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.17+0.00 (+1.95%)

Close on Nov 20, 2026Market cap $415.59KP/E –Yield –

Arcadia Biosciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Arcadia Biosciences's free cash flow for the twelve months ending Dec 31, 2025 was -$4.70M. For fiscal 2025 it was -$4.70M. The highest annual figure on record is -$4.70M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.70M–
FY2024Dec 31, 2024-$9.64M–
FY2023Dec 31, 2023-$15.30M–
FY2022Dec 31, 2022-$14.05M–
FY2021Dec 31, 2021-$26.88M–
FY2020Dec 31, 2020-$32.55M–
FY2019Dec 31, 2019-$18.68M–
FY2018Dec 31, 2018-$13.88M–
FY2017Dec 31, 2017-$14.04M–
FY2016Dec 31, 2016-$17.29M–
FY2015Dec 31, 2015-$15.26M–
FY2014Dec 31, 2014-$14.94M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$822.00K–
Q3 FY2025Sep 30, 2025-$257.00K–
Q2 FY2025Jun 30, 2025-$2.03M–
Q1 FY2025Mar 31, 2025-$1.59M–
Q4 FY2024Dec 31, 2024-$2.21M–
Q3 FY2024Sep 30, 2024-$1.75M–
Q2 FY2024Jun 30, 2024-$2.46M–
Q1 FY2024Mar 31, 2024-$3.22M–
Q4 FY2023Dec 31, 2023-$4.15M–
Q3 FY2023Sep 30, 2023-$2.89M–
Q2 FY2023Jun 30, 2023-$4.80M–
Q1 FY2023Mar 31, 2023-$3.47M–
Q4 FY2022Dec 31, 2022-$2.38M–
Q3 FY2022Sep 30, 2022-$3.37M–
Q2 FY2022Jun 30, 2022-$3.37M–
Q1 FY2022Mar 31, 2022-$4.93M–
Q4 FY2021Dec 31, 2021-$6.75M–
Q3 FY2021Sep 30, 2021-$8.47M–
Q2 FY2021Jun 30, 2021-$6.46M–
Q1 FY2021Mar 31, 2021-$5.19M–
Q4 FY2020Dec 31, 2020-$7.05M–
Q3 FY2020Sep 30, 2020-$7.21M–
Q2 FY2020Jun 30, 2020-$8.25M–
Q1 FY2020Mar 31, 2020-$10.05M–
Q4 FY2019Dec 31, 2019-$5.61M–
Q3 FY2019Sep 30, 2019-$4.32M–
Q2 FY2019Jun 30, 2019-$4.69M–
Q1 FY2019Mar 31, 2019-$4.06M–
Q4 FY2018Dec 31, 2018-$2.86M–
Q3 FY2018Sep 30, 2018-$4.04M–
Q2 FY2018Jun 30, 2018-$4.34M–
Q1 FY2018Mar 31, 2018-$2.65M–
Q4 FY2017Dec 31, 2017-$2.69M–
Q3 FY2017Sep 30, 2017-$2.38M–
Q2 FY2017Jun 30, 2017-$4.39M–
Q1 FY2017Mar 31, 2017-$4.59M–
Q4 FY2016Dec 31, 2016-$4.29M–
Q3 FY2016Sep 30, 2016-$3.96M–

More Arcadia Biosciences figures

See a number that looks wrong?